Q2 Results
Dr Reddy's Q2 consolidated net profit rises over 7% on year to INR 13.47 bln
This story was originally published at 16:42 IST on 24 October 2025
Register to read our real-time news.Informist, Friday, Oct. 24, 2025
MUMBAI – Dr. Reddy's Laboratories Ltd.'s consolidated net profit for the quarter ended September rose over 7% to INR 13.47 billion from INR 12.56 billion a year ago but was lower than analysts' estimate of INR 14.04 billion. The company's consolidated revenue for the quarter was INR 88.28 billion, up nearly 10% from INR 80.38 billion a year ago.
* Dr Reddy's Jul-Sept consol net profit INR 13.47 bln
* Analysts saw Dr Reddy's Jul-Sept consol net profit at INR 14.04 bln
* Analysts saw Dr Reddy's Jul-Sept consol revenue at INR 87 bln
* Dr Reddy's Jul-Sept consol revenue INR 88.28 bln
* Dr Reddy's Jul-Sept consol PAT INR 13.47 bln vs INR 12.56 bln year ago
* Dr Reddy's Jul-Sept consol revenue INR 88.28 bln vs INR 80.38 bln year ago
* Dr Reddy's Apr-Sept consol PAT INR 27.65 bln vs INR 26.48 bln year ago
* Dr Reddy's Apr-Sept consol revenue INR 174.00 bln vs INR 157.34 bln yr ago
More to follow
To read more please subscribe
Share this Story:
